Atomoxetine now available as oral solution

Further information
View Strattera Oral Solution drug record
Summary of Product Characteristics
Manufacturer: Lilly

Strattera Oral Solution is licensed for the treatment of children, adolescents and adults with ADHD.

The liquid can be prescribed from the age of 6 years. The amount of solution to be given in children is dependent on body weight. To facilitate dosing, the product is packaged with a 10ml oral syringe marked in 1ml increments.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

SGLT2 inhibitors: MHRA warns of Fournier's gangrene risk

Cases of necrotising fasciitis of the genitalia or...

New advice for carbimazole over malformation and pancreatitis risks

New advice for carbimazole over malformation and pancreatitis risks

Reports of congenital malformations and acute pancreatitis...

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Potential sensitising agents in eye drops and ointments.

Antibiotic Treatments in Adults, Summary of Regimens

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.